Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.04B |
| 2 |
Verizon
VZ
|
+$459M |
| 3 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$448M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$738M |
| 2 |
iShares MBS ETF
MBB
|
+$390M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$216M |
| 4 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$202M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.49% |
| 2 | Financials | 13.78% |
| 3 | Healthcare | 13.39% |
| 4 | Industrials | 9.54% |
| 5 | Consumer Discretionary | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNTY
2876
DELISTED
Guaranty Bancshares
GNTY
| $758K | ﹤0.01% |
21,871
+416
| +2% | +$14.7K |
|
2877
South Plains Financial
SPFI
$845M
| $755K | ﹤0.01% |
27,409
-538
| -2% | -$16K |
|
|
SMMF
2878
DELISTED
Summit Financial Group, Inc.
SMMF
| $754K | ﹤0.01% |
30,305
+2,424
| +9% | +$66.8K |
|
2879
Vera Therapeutics
VERA
$2.3B
| $752K | ﹤0.01% |
38,859
+969
| +3% | +$17.5K |
|
2880
Tyra Biosciences
TYRA
$1.9B
| $749K | ﹤0.01% |
98,503
+2,328
| +2% | +$16.5K |
|
|
FRGE
2881
DELISTED
Forge Global Holdings
FRGE
| $746K | ﹤0.01% |
28,740
-5,837
| -17% | -$133K |
|
2882
Inspired Entertainment
INSE
$184M
| $743K | ﹤0.01% |
58,659
+237
| +0.4% | +$2.63K |
|
|
BNFT
2883
DELISTED
Benefitfocus, Inc.
BNFT
| $738K | ﹤0.01% |
70,562
+1,677
| +2% | +$15.1K |
|
2884
Park Aerospace
PKE
$737M
| $736K | ﹤0.01% |
54,866
+1,426
| +3% | +$17.2K |
|
|
DBD
2885
DELISTED
Diebold Nixdorf Incorporated
DBD
| $734K | ﹤0.01% |
516,840
-22,124
| -4% | -$47.5K |
|
|
BHR
2886
Braemar Hotels & Resorts
BHR
$156M
| $734K | ﹤0.01% |
178,567
+3,387
| +2% | +$13.9K |
|
2887
Ouster
OUST
$2.63B
| $732K | ﹤0.01% |
84,816
+7,325
| +9% | +$79.8K |
|
|
DADA
2888
DELISTED
Dada Nexus
DADA
| $731K | ﹤0.01% |
104,866
+13,912
| +15% | +$72.8K |
|
2889
Adicet Bio
ACET
$85.2M
| $726K | ﹤0.01% |
5,073
+366
| +8% | +$91.3K |
|
|
JBIO
2890
Jade Biosciences
JBIO
$1.2B
| $722K | ﹤0.01% |
704
+25
| +4% | +$18.1K |
|
|
GRNA
2891
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
| $718K | ﹤0.01% |
608,813
+130,162
| +27% | +$212K |
|
2892
Primis Financial Corp
FRST
$399M
| $713K | ﹤0.01% |
60,179
+1,222
| +2% | +$15K |
|
2893
Northeast Bank
NBN
$1.06B
| $713K | ﹤0.01% |
16,933
+386
| +2% | +$16.2K |
|
2894
Arbutus Biopharma
ABUS
$857M
| $711K | ﹤0.01% |
305,280
+17,861
| +6% | +$42.7K |
|
|
CYXT
2895
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
| $711K | ﹤0.01% |
370,400
+3,798
| +1% | +$8.97K |
|
2896
BCB Bancorp
BCBP
$173M
| $710K | ﹤0.01% |
39,490
+887
| +2% | +$16.6K |
|
2897
HCI Group
HCI
$2.23B
| $710K | ﹤0.01% |
17,922
+172
| +1% | +$6.33K |
|
2898
Lennar Class B
LEN.B
$19.4B
| $709K | ﹤0.01% |
9,979
+81
| +0.8% | +$5.26K |
|
2899
Omeros
OMER
$857M
| $706K | ﹤0.01% |
312,409
+4,170
| +1% | +$11.5K |
|
2900
Karyopharm Therapeutics
KPTI
$43.5M
| $703K | ﹤0.01% |
13,789
+422
| +3% | +$29.3K |
|
Similar funds
Charles Schwab's Q4 2022 Portfolio in Review
As of Q4 2022, Charles Schwab held 3,632 positions worth $310B, up 11% from $279B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Charles Schwab's Q4 2022 filing shows 124 new, 2,654 increased, 459 reduced and 86 closed positions. Its largest new stake was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M. The largest sale was Vanguard Intermediate-Term Treasury ETF, an estimated $738M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2022 buy was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M.
- Charles Schwab added most to iShares 7-10 Year Treasury Bond ETF in Q4 2022, an estimated $1.04B increase.
- Charles Schwab's biggest Q4 2022 reduction was Vanguard Intermediate-Term Treasury ETF, cutting an estimated $738M.
- Charles Schwab fully exited Duke Realty Corp. in Q4 2022, selling an estimated $175M.
- Charles Schwab's ten largest holdings make up 16% of its $310B portfolio in Q4 2022.
- Charles Schwab opened 124 new positions and closed 86 in Q4 2022.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $310B.
Based on Charles Schwab's 13F filing for Q4 2022, filed 13 Feb 2023.